References
1. Ljunberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F et
al. Guidelines on
renal cell carcinoma. EAU Guidelines, 2014.
2. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management
of the clinical
T1 renal mass. J Urol 2009;182(4):1271–9.
3. Wingo MS, Leveillee RJ. Central and deep renal tumors can be
effectively ablated:
radiofrequency ablation outcomes with fiberoptic peripheral temperature
monitoring. J
Endourol 2008;22(6):1261–7.
4. Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial
tumor ablation (RITA)
is a possible new modality for treatment of renal cancer: ex vivo and in
vivo experience. J
Endourol 1997;11(4):251-8.
5. Gervais DA, McGovern FJ, Arellano RS, et al. Radiofrequency ablation
of renal cell
carcinoma: part 1, Indications, results, and role in patient management
over a 6-year period
and ablation of 100 tumors. AJR Am J Roentgenol 2005;185(1):64-71.
6. Matsumoto ED, Johnson DB, Ogan K, et al. Shortterm efficacy of
temperature-based
radiofrequency ablation of small renal tumors. Urology
2005;65(5):877-81.
7. Park SH, Yoon SK, Cho JH, et al. Radiofrequency ablation treatment
for renal cell
carcinoma: early clinical experience. Korean J Radiol 2008;9(4):340-7.
8. Best SL, Park SK, Youssef RF et al: Long-term outcomes of renal tumor
radio frequency
ablation stratified by tumor diameter: size matters. J Urol 2012; 187:
1183.
9.Leveillee RJ, Castle SM, Gorbatiy V et al: Oncologic outcomes using
real-time peripheral
thermometry-guided radiofrequency ablation of small renal masses. J
Endourol 2013; 27: 480.
10. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising
incidence of small
renal masses: a need to reassess treatment effect. J Natl Cancer Inst.
2006;98(18):1331-4.
Epub 2006/09/21.
11. Wah TM, Irving HC, Gregory W, Cartledge J, Joyce AD, Selby J.
Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience
in 200 tumours.
BJU Int. 2014 Mar;113(3):416-28. doi: 10.1111
12. Mylona S, Kokkinaki A, Pomoni M, et al. Percutaneous radiofrequency
ablation of renal
cell carcinomas in patients with solitary kidney: 6 years experience.
Eur J Radiol
2009;69(2):351-6.
13. Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais
DA. Longterm oncologic outcomes after radiofrequency ablation for T1
renal cell carcinoma. Eur
Urol. 2013 Mar;63(3):486-92. doi: 10.101631.
14. Gontero P, Joniau S, Zitella A, Tailly T, Tizani A, Van Poppel H, et
al. Ablative therapies
in the treatment of small renal tumors:how far from standard of care?
Urologic Oncology
Seminars and Original Investigations 28: 251-259, 2010.
15. Aron M, Gill IS. Renal tumor ablation. Curr Opin Urol
2005;15(5):298-305.
16. Kwan KG, Matsumoto ED. Radiofrequency ablation and cryoablation of
renal tumours.
Curr Oncol 2007;14(1):34-8.
17. Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Kurup AN, Weisbrod
AJ, et al
Percutaneous ablation of renal masses measuring 3.0 cm and smaller:
comparative local
control and complications after radiofrequency ablation and
cryoablation. AJR Am J
Roentgenol. 2013 Feb;200(2):461-6. doi: 10.2214
18. Mershon JP, Tuong MN, Schenkman NS. Thermal ablation of the small
renal mass: a
critical analysis of current literature. Minerva Urol Nefrol. 2020
Apr;72(2):123-134. doi:
10.23736/S0393-2249.19.03572-0. Epub 2019 Dec 12.